Pfizer buys stake in French vaccine maker Valneva
US pharma group to pay €90.5mn for 8% in deal that will boost joint Lyme disease programme
Source
CorpDev.Org
Deal Intelligence Platform & Services for Global M&A / PE
Deal Intelligence Platform & Services for Global M&A / PE